The heterogeneous composition of vaccine formulations and the relatively low concentration make the characterization of the protein antigens extremely challenging. Aluminum-containing adjuvants have been used to enhance the immune response of several antigens over the last 90 years and still remain the most commonly used. Here, we show that solid-state NMR and isotope labeling methods can be used to characterize the structural features of the protein antigen component of vaccines and to investigate the preservation of the folding state of proteins adsorbed on Alum hydroxide matrix, providing the way to identify the regions of the protein that are mainly affected by the presence of the inorganic matrix. L-Asparaginase from E. coli has been used as a pilot model of protein antigen. This methodology can find application in several steps of the vaccine development pipeline, from the antigen optimization, through the design of vaccine formulation, up to stability studies and manufacturing process.
Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation / Cerofolini L.; Giuntini S.; Ravera E.; Luchinat C.; Berti F.; Fragai M.. - In: NPJ VACCINES. - ISSN 2059-0105. - STAMPA. - 4:(2019), pp. 20-20. [10.1038/s41541-019-0115-7]
Structural characterization of a protein adsorbed on aluminum hydroxide adjuvant in vaccine formulation
Cerofolini L.;Giuntini S.;Ravera E.;Luchinat C.;Fragai M.
Conceptualization
2019
Abstract
The heterogeneous composition of vaccine formulations and the relatively low concentration make the characterization of the protein antigens extremely challenging. Aluminum-containing adjuvants have been used to enhance the immune response of several antigens over the last 90 years and still remain the most commonly used. Here, we show that solid-state NMR and isotope labeling methods can be used to characterize the structural features of the protein antigen component of vaccines and to investigate the preservation of the folding state of proteins adsorbed on Alum hydroxide matrix, providing the way to identify the regions of the protein that are mainly affected by the presence of the inorganic matrix. L-Asparaginase from E. coli has been used as a pilot model of protein antigen. This methodology can find application in several steps of the vaccine development pipeline, from the antigen optimization, through the design of vaccine formulation, up to stability studies and manufacturing process.File | Dimensione | Formato | |
---|---|---|---|
s41541-019-0115-7.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
2.22 MB
Formato
Adobe PDF
|
2.22 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.